Baylor's clinical exome enhances coverage of over 3,600 genes and the lab has also validated Illumina's HiSeq X Ten for its research pipeline.
Elaine Mardis, co-director of the Genome Institute at Washington University in St. Louis, discussed genomic testing for cancer in both clinical research and diagnosis.
The company plans to bring both tissue-based and blood-based targeted sequencing tests through FDA clearance.
The companies are taking the CE-IVD route as opposed to the LDT model in the US due to Europe's distributed prenatal testing market and lower regulatory hurdles.
At the Molecular Medicine Tri-Conference, Guardant Health presented details from a 510-patient clinical validation study.
In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.
The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.
A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.
National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.